logo
logo

nference Completes $60M Series C to Accelerate and Expand Augmented Intelligence for Life Sciences

Dec 15, 2020•over 4 years ago

Amount Raised

$60 Million

Round Type

series c

Cambridge

Description

 nference, which synthesizes the world's biomedical knowledge, announced completion of a $60 million Series C funding round led by Matrix Capital Management, along with Matrix Partners, Mayo Clinic Ventures and NTTVC.

Company Information

Company

Nference

Location

Cambridge, Maryland, United States

About

Through its augmented intelligence nferXTM software platform, nference synthesizes exponentially growing storehouses of siloed biomedical knowledge into actionable insights. State-of-the-art neural networks are trained to deliver real-time, automated intelligence extracted from scientific, clinical, regulatory and commercial data sets. The platform supports a diverse set of applications across the life-sciences ecosystem. nference is headquartered in Cambridge, MA. Follow nference on LinkedIn and Twitter. Visit us at nference.ai.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech